Perspectives of data science in preclinical safety assessment-Reference-Cited by-同舟云学术

Perspectives of data science in preclinical safety assessment

Published:2023-08 Issue:8 Volume:28 Page:103642
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Steger-Hartmann Thomas^ORCID,Kreuchwig Annika^ORCID,Wang Ken^ORCID,Birzele Fabian^ORCID,Draganov Dragomir^ORCID,Gaudio Stefano^ORCID,Rothfuss Andreas^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference64 articles.

1. Computer-based prediction models in regulatory toxicology;Steger-Hartmann,2021

2. Benchmark data set for in silico prediction of Ames mutagenicity;Hansen;J Chem Inf Model,2009

3. In silico prediction of hERG potassium channel blockage by chemical category approaches;Zhang;Toxicol Res,2016

4. Data standardization, pharmaceutical drug development, and the 3Rs;Kaufman;ILAR J,2016

5. The FAIR Guiding Principles for scientific data management and stewardship;Wilkinson;Sci Data,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach;Toxicology and Applied Pharmacology;2024-10

2. Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studies;Regulatory Toxicology and Pharmacology;2024-06

3. Big data and its impact on the 3Rs: a home cage monitoring oriented review;Frontiers in Big Data;2024-05-20

4. A minimal metadata set (MNMS) to repurpose nonclinical in vivo data for biomedical research;Lab Animal;2024-03

5. Can Historical Control Group Data Be Used to Replace Concurrent Controls in Animal Studies?;Toxicologic Pathology;2023-10-31